Liver Stiffness Measurements Using Acoustic Radiation Force Impulse in Recipients of Living-Donor and Deceased- Donor Orthotopic Liver Transplant
|
|
- Prosper Scott
- 5 years ago
- Views:
Transcription
1 ArtIcle Liver Stiffness Measurements Using Acoustic Radiation Force Impulse in Recipients of Living-Donor and Deceased- Donor Orthotopic Liver Transplant Kemal Murat Haberal, 1 Hale Turnaoğlu, 1 Adnan Özdemir, 1 Nihal Uslu, 1 Asuman Nihan Haberal Reyhan, 2 Gökhan Moray, 3 Mehmet Haberal 3 Abstract Objectives: The aim of this study was to evaluate the diagnostic efficiency of the acoustic radiation force impulse (Siemens Medical Solutions, Erlangen, Germany) elastography in assessment of fibrosis in orthotopic liver transplant patients. Materials and Methods: We enrolled 28 orthotopic liver transplant patients (deceased and living donors), whose biopsy decision had been prospectively given clinically. Ten acoustic radiation force impulse elastographic measurements were applied before the biopsy or within 3 days after the biopsy by 2 radiologists. After the core tissue needle biopsy, specimens of all patients were analyzed according to the modified Ishak scoring system. Measurements of acoustic radiation force impulse elastography and pathology specimen results were compared. Results: From 28 biopsies, fibrosis scores of 4 biopsies were evaluated as F0 (14.3%), 16 as F1 (57.1%), 4 as F2 (14.3%), and 4 as F3 (14.3%). Mean results of acoustic radiation force impulse measurements were calculated as 1.4 ± 0.07 in F0, 1.74 ± 0.57 in F1, 2.19 ± 0.7 in F2, and 2.18 ± 0.35 in F3. There were no significant correlations of mean acoustic radiation force impulse values between the F0 versus F1 (P =.956) and F0 versus F2 stages (P =.234). A statistically significant correlation of mean acoustic radiation force impulse values was found between the F0 and F3 fibrosis stages (P =.046). Conclusions: Acoustic radiation force impulse imaging is a promising screening test for detecting significant liver fibrosis ( F3 in modified Ishak) in living-donor or deceased-donor orthotopic liver transplant recipients. From the 1 Department of Radiology, the 2 Department of Pathology, and the 3 Department of General Surgery, Baskent University School of Medicine, Ankara, Turkey Acknowledgements: The authors have no sources of funding for this study and have no conflicts of interest to declare. Corresponding author: Kemal Murat Haberal, Maresal Fevzi Cakmak Rd., 10 st., No/ Bahcelievler, Ankara, Turkey Phone: kmhbjk@hotmail.com Experimental and Clinical Transplantation (2017) Key words: Liver biopsy, Liver fibrosis, Metavir, Transient elastography, Ultrasonography Introduction Liver transplant is the only treatment option for advanced liver disease. However, after liver trans - plant, acute complications (including primary dysfunction, hepatic artery thrombosis, portal vein thrombosis, hepatic venous obstruction, bile leak, and biliary stricture) or chronic complications (including chronic rejection, disease recurrence, and drug-induced complications) may occur. 1-3 Post - transplant liver dysfunction can have various causes; evaluation of the causes, which can lead to diffuse parenchymal damage, including fibrosis, is of clinical importance. Postoperative B-mode and Doppler ultrasono - graphy (US) are standard procedures for the assessment of graft complications. From US findings, clinical symptoms, and abnormal laboratory findings, a liver biopsy may be required. 4 Although liver biopsy is the standard method for the assessment of morphologic liver changes and fibrosis, it is an invasive procedure that may cause complications. 5 Transient elastography (TE) is currently the most widely used and endorsed method for the asses sment of liver fibrosis in many conditions, such as chronic hepatitis B and C, nonalcoholic steatohepatitis, and nonalcoholic fatty liver disease, as well as in posttransplant patients. 6 Insufficient performance in detecting mild fibrosis, failure to measure liver elasticity in patients with obesity, ascites, and narrow intercostal space, and inability to target liver parenchyma by direct visualization are problems that remain a considerable adversity of this tool. 7,8 Acoustic radiation force impulse (ARFI; Siemens Medical Solutions, Erlangen, Germany) elastography is a new technology to measure liver stiffness and Copyright Başkent University 2017 Printed in Turkey. All Rights Reserved. DOI: /ect
2 evaluate liver fibrosis. This technology is included in conventional ultrasonographic devices, and it can be performed during a conventional B-mode exami - nation with a single transducer. The principle of this method is based on the shearing of the examined tissue, which induces a smaller strain in hard tissues than in soft ones. The US probe produces an acustic pulse, which generates shear waves that propagate into the tissue. The propagation speed (measured in meters per second) increases with the stage of the fibrosis. 6 It has been shown that ARFI is a reliable technique for diagnosing or excluding liver cirrhosis 9-11 and shows similar predictive value for significant fibrosis and cirrhosis compared with TE. 6 However, the standard cut off value of the ARFI technique is not yet well established in the clinical care of liver transplant patients. The aim of this study was to evaluate the diagnostic efficiency of the ARFI technology for the assessment of fibrosis in patients who received orthotopic liver transplant (OLT). Materials and Methods We enrolled 28 OLT patients (deceased and living donors), whose biopsy decision was made clinically because of posttransplant dysfunction, for pro - spective evaluation of cause and severity of fibrosis. The ARFI elastographic measurements were applied before the biopsy or within 3 days after the biopsy, by 2 radiologists. The local ethics committee approved the project, and written informed consent was obtained from all patients for the use of their data for research. For ARFI elastographic measurements, we used the Siemens Acuson S3000 ultrasonographic system with 6C1 transducer (Virtual Touch Tissue Quantification; Siemens Medical Solutions). For measurement, a quadratic cursor representing the anatomic region of interest to be measured is placed in the requested area of the liver parenchyma, and numerical values are obtained. Ten measurements in segments III to IV on the left lobe graft and segments VII to VIII on the right lobe graft could be obtained, avoiding large vessels or bile ducts. The measurements were performed about 2 to 3 cm in depth from the surface of the liver, with results expressed as meters per second. For liver biopsy, our interventional radiology department used a US-guided procedure with a core tissue needle (18G; 2-cm sample notch). Biopsy specimens of all patients were analyzed by an experienced pathologist in our institution. The fibrosis stage was determined according to the modified Ishak scoring system. The fibrosis scores are defined as follows: 0, no fibrosis; 1, fibrous expansion of some portal areas, with or without short fibrous septa; 2, fibrous expansion of most portal areas, with or without short fibrous septa; 3, fibrous expansion of most portal areas with occasional portal to portal bridging; 4, fibrous expansion of most portal areas with marked bridging (portal to portal as well as portal to central); 5, marked bridging with occasional nodules (incomplete cirrhosis); and 6, cirrhosis, probable or definite. 10 Mean ± standard deviation, median, minimum, and maximum values are used here to describe the quantitative variables. In addition, frequency and percentages are given for nominal data. Normality assumption was checked by Shapiro-Wilks test, and it was found that data did not conform to normal distribution. The distributions of ARFI measurements were compared among fibrosis groups with the nonparametric Kruskal- Wallis (with Conover-Dunn multiple comparison test) and Mann-Whitney U tests. For all analyses, SPSS version 21.0 software was used (SPSS: An IBM Company, IBM Corporation, Armonk, NY, USA), and statistical significance was set at P <.05. Measurements of ARFI sonoelastography and results of pathology specimens were compared. Results Our study included 28 patients who received livingdonor or deceased-donor OLT (16 men [57.1%] and 12 women [42.9%]). Median age was 33.8 years (range, 4-66 y), and median time period from OLT to liver biopsy was 43.7 months (range, mo). Causes for liver transplant were hepatitis B virus infection (9 patients), hepatitis C virus infection (4 patients), cryptogenic cirrhosis (4 patients), Wilson disease (3 patients), Budd-Chiari syndrome (2 patients), biliary atresia (2 patients), intoxication (1 patient), Alagille syndrome (1 patient), and fulminant hepatitis A (1 patient). Of 28 patients, 5 patients (17.9%) received deceased-donor grafts and 23 patients (82.1%) received living-donor grafts. The mean value of the depth of ARFI measurements was 3 ± 0.5 cm. Of the 28 biopsies, 4 (14.3%) were evaluated as fibrosis score F0, 16 (57.1%) were evaluated as fibrosis score F1, 4 (14.3%) were evaluated as fibrosis
3 score F2, and 4 (14.3%) were evaluated as fibrosis score F3. There were no specimens with fibrosis scores evaluated as F4, F5, or F6. The mean ARFI measure - ments were 1.4 ± 0.07 m/s in F0, 1.74 ± 0.57 m/s in F1, 2.19 ± 0.7 m/s in F2, and 2.18 ± 0.35 m/s in F3. We found that mean ARFI values between F0 and the other fibrosis stages (F1, F2, and F3) were signifi - cantly correlated (P =.042). When the correlation between F0 and the other fibrosis stages were analyzed separately, there were no significant correlation of mean ARFI values between the F0 versus F1 (P =.956) and F0 versus F2 (P =.234). A statistically significant correlation of mean ARFI values was found between the F0 and F3 fibrosis stages (P =.046) (Figures 1 and 2). Figure 3 shows box plots for ARFI measurements versus stages of fibrosis. Figure 3. Liver Stiffness Measurements by Acoustic Radiation Force Impulse İmaging Versus Stages of Fibrosis Liver stiffness was expressed as the velocity of the shear wave (m/s). Boxes represent upper and lower quartiles; horizontal lines represent median values. Box plots show the significantly higher acoustic radiation force impulse (ARFI) values in patients with F3 portal fibrosis versus the F0 group (by modified Ishak scoring). Statistical analysis was performed with Kruskal-Wallis test. P < Figure 1. Ultrasonography and Pathology Specimen Results of an Orthotopic Liver Transplant Patient With Fibrosis Stage (Modified Ishak) F3 (A) Acoustic radiation force impulse (ARFI) elastography during real-time B-mode ultrasonography. Quadratic cursor was placed in the region-of-interest (white box), showing intercostal approach in the left liver lobe (segment IVa). ARFI shear-wave-velocities (Vs) are displayed in m/s and the depth of measurement in centimeters. (B) Pathology specimen. Portal to portal bridging necrosis is observed (F3) (Masson trichrome 200 magnification). Figure 2. Ultrasonography and Pathology Specimen Results of an Orthotopic Liver Transplant Patient With Fibrosis Stage (Modified Ishak) F1 (A)Acoustic radiation force impulse (ARFI) elastography during real-time B-mode ultrasonography. Quadratic cursor was placed in the region-of-interest (white box), showing intercostal approach in the right liver lobe (segment VIII). ARFI shear-wave-velocities (Vs) are displayed in m/s and the depth of measurement in centimeters. (B) Pathology specimen. Fibrous expansion of a portal area, with short fibrous septa is seen (F1) (Masson trichrome at 200 magnification).
4 Discussion Our study revealed a significant correlation between ARFI values and liver fibrosis in post-olt patients. The ARFI values increased in parallel with fibrosis staging but were not accurate enough to differentiate between F0 and F1 or F2 fibrosis stages in accordance with the modified Ishak scoring system. The evaluation of liver parenchyma in terms of liver fibrosis in posttransplant liver grafts is a crucial issue. The detection of early stages of fibrosis in these patients is specifically important. In the literature, previous studies have evaluated post-olt fibrosis with ARFI elastography, with pathologic evaluations done by the METAVIR, Batts-Ludwig, or Scheuer scoring systems. The METAVIR, Batts-Ludwig, and Scheuer scoring systems are almost similar, and they all have 4 categories. Modified Ishak and METAVIR scores are widely accepted scoring systems for assessment of fibrosis and necroinflammation. Modified Ishak and METAVIR are nearly identical systems. However, modified Ishak is a wider scale. Despite METAVIR, which determines the grade of the activity of interface hepatitis and lobular necrosis, the Ishak system detects portal infiltrate and confluent necrosis with the 2 previous parameters. 12,13 Unlike other scoring systems, there are 6 categories in the modified Ishak scoring system. Compared with the METAVIR scoring system, in the modified Ishak scoring system, F1 and F2 are equal to F1, F3 is equal to F2, F4 and F5 are equal to F3, and F6 is equal to F4. The METAVIR system is more reproducible but is less effective for monitoring minor changes. 13 Goodman and associates suggested application of METAVIR in routine work and the application of the modified Ishak score in clinical trials because of its higher sensitivity in fibrosis assessment. 14 The major difference of our study from other studies in the literature is that we used the modified Ishak scoring system, which allows monitoring minor changes in fibrosis, and conducted ARFI elastographic evalu - ations in the early fibrosis stages. Noninvasive methods such as ARFI or TE have gained increased importance in the follow-up of patients after OLT. Both techniques provide accurate diagnosis of significant fibrosis and cirrhosis. 7,15,16 Assessment of fibrosis can be examined quickly and noninvasively in this group of patients by TE. However, TE has many limitations in measurement. The performance of TE may be limited in patients with a high body mass index, ascites, or narrow intercostal space. 15,17 Conventional US devices include ARFI; therefore, B mode information and the elastography measure - ment can be performed quickly using a single device, as in TE. 11,18 The US-guided device makes it possible to identify the most appropriate place for the elastographic measurements, for instance avoiding nearby interfering structures, such as hepatic vessels and ascites. 19 In nontransplant patients, regarding the accuracy of ARFI imaging in cirrhotic liver disease, several studies have reported that ARFI imaging provides good diagnostic performance and excellent accuracy, with ARFI values increasing in parallel with fibrosis stage. 15,16,20 In their study, Sporea and associates 16 reported that ARFI was wellcorrelated with liver fibrosis caused by viral hepatitis; however, ARFI was not accurate enough to differentiate between F1 versus F2 due to the small proportion of F0 and F1 patients (by METAVIR scoring). Crespo and associates 18 indicated high accuracy only in advanced fibrosis stages (by Scheuer scoring) of liver fibrosis with ARFI imaging, in transplant and nontransplant patients with liver disease of various causes. For fibrosis staging by ARFI elastography in post- OLT patients, only few experiences are published in the literature. 5,18,21-23 Liao and associates 21 reported a sensitivity ratio of 95.5% using a shear-wave velocity cutoff value of m/s in the evaluation of posttransplant graft dysfunction in early fibrosis stages ( F1, by METAVIR scoring); which constituted a larger proportion of the study group (94.5%). The group indicated that there was a significant difference in F0 compared with F1. They also reported that ARFI measurements had a high specificity (92.9%) using a cutoff value of 1.8 m/s in the advanced fibrosis stages. However, Wildner and associates 4 reported that the areas under the receiver operating characteristic curves for patients with advanced fibrosis (F3) and cirrhosis (F4) (by Batts-Ludwig scoring) were 92.9% and 80% and had discretely higher cutoff values ( F1, 1.48 m/s). Pinto and associates 22 indicated a statistically significant difference in shear-wave velocities between the F0-F1 and F2-F4 groups (by Batts-Ludwig scoring), concluding that ARFI might serve as a potential method for assessing significant fibrosis in pediatric patients after liver transplant. Tomita and associates 23 reported that the ARFI measurements were significantly higher for patients
5 with F1 and F2 portal fibrosis versus patients with F0 portal fibrosis (by METAVIR scoring). In the present study, we found mean ARFI values of 2.18 ± 0.35 m/s for patients with F3 fibrosis (by modified Ishak scoring), whereas the shear-wave velocities in patients with F0 fibrosis were significantly lower (1.4 ± 0.07 m/s). The cutoff values that were reported by Wildner and associates 4 seem to be closer to our ARFI measurements. When the lower cutoff values were considered, which were determined by Liao and associates, 21 there was only 1 patient under the threshold with F1 (by modified Ishak scoring) fibrosis in our patient group. However, with regard to this threshold, specificity decreases prominently (reported 25.7% in F1 stage fibrosis by METAVIR scoring). In our study, there was no significant correlation of mean ARFI values between F0 versus F1 and F2 (by modified Ishak scoring) stages that corresponded to F1 in METAVIR scoring, as opposed to that shown by Liao and associates 21 and Tomita and associates. 23 However, there was a statistically significant correlation of mean ARFI values, which was found between F0 and F3 (by modified Ishak scoring) fibrosis stages that corresponded to F2 in METAVIR scoring, unlike the studies of Sporea and associates 16 and Crespo and associates, 18 which indicated a significant correlation in higher fibrosis stages. In overall evaluations, it seems that a clear detection of fibrosis can be possible in more advanced fibrosis stages ( F2 in METAVIR and similar scoring systems; F3 in modified Ishak). There were some limitations in our study. The most important limitation was the small sample size due to the small number of patients with significant fibrosis and, in particular, none with cirrhosis. In conclusion, ARFI imaging is a promising screening test for detecting significant liver fibrosis ( F2 in METAVIR and similar scoring systems, F3 in modified Ishak) in patients after living-donor or deceased-donor OLT. Although similar results have been published indicating the accuracy of ARFI in advanced fibrosis stages, for detection of early fibrosis stages, further multicentric prospective studies with larger series of patients are needed. These studies could help obtain clear cutoff ARFI values, which may help to confirm the effectiveness of this method in diagnosing liver fibrosis in post- OLT patients. References 1.Lucey MR, Terrault N, Ojo L, et al. Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl. 2013;19(1): Singh AK, Nachiappan AC, Verma HA, et al. Postoperative imaging in liver transplantation: what radiologists should know. Radiographics. 2010;30(2): Moreno R, Berenguer M. Post-liver transplantation medical complications. Ann Hepatol. 2006;5(2): Wildner D, Strobel D, Konturek PC, et al. Impact of acoustic radiation force impulse imaging in clinical practice of patients after orthotopic liver transplantation. Med Sci Monit. 2014;20: Filingeri V, Francioso S, Sforza D, Santopaolo F, Oddi FM, Tisone G. A retrospective analysis of percutaneous liver biopsies performed in patients with liver transplantation or liver disease: ultrasonography can reduce complications? Eur Rev Med Pharmacol Sci. 2016;20(17): Bota S, Herkner H, Sporea I, et al. Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis. Liver Int. 2013;33(8): Friedrich-Rust M, Ong MF, Martens S, et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology. 2008;134(4): Talwalkar JA, Kurtz DM, Schoenleber SJ, West CP, Montori VM. Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2007;5(10): Friedrich-Rust M, Wunder K, Kriener S, et al. Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography. Radiology. 2009;252(2): Boursier J, Isselin G, Fouchard-Hubert I, et al. Acoustic radiation force impulse: a new ultrasonographic technology for the widespread noninvasive diagnosis of liver fibrosis. Eur J Gastroenterol Hepatol. 2010;22(9): Goertz RS, Zopf Y, Jugl V, et al. Measurement of liver elasticity with acoustic radiation force impulse (ARFI) technology: an alternative noninvasive method for staging liver fibrosis in viral hepatitis. Ultraschall Med. 2010;31(2): Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22(6): Takahashi H. Liver biopsy. In: Shiha G, Zalata K, eds. Ishak versus METAVIR: Terminology, Convertibility and Correlation with Laboratory Changes in Chronic Hepatitis C. Rijeka, Croatia: InTech Europe; 2011: Goodman ZD. Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol. 2007;47: Nierhoff J, Chavez Ortiz AA, Herrmann E, Zeuzem S, Friedrich-Rust M. The efficiency of acoustic radiation force impulse imaging for the staging of liver fibrosis: a meta-analysis. Eur Radiol. 2013;23(11): Sporea I, Sirli R, Bota S, et al. Is ARFI elastography reliable for predicting fibrosis severity in chronic HCV hepatitis? World J Radiol. 2011;3(7): Kim BK, Fung J, Yuen MF, Kim SU. Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectives. World J Gastroenterol. 2013;19(12): Crespo G, Fernandez-Varo G, Marino Z, et al. ARFI, FibroScan, ELF, and their combinations in the assessment of liver fibrosis: a prospective study. J Hepatol. 2012;57(2): Berzigotti A, Abraldes JG, Tandon P, et al. Ultrasonographic evaluation of liver surface and transient elastography in clinically doubtful cirrhosis. J Hepatol. 2010;52(6): Friedrich-Rust M, Nierhoff J, Lupsor M, et al. Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta-analysis. J Viral Hepat. 2012;19(2):e
6 21. Liao CC, Chen TY, Tsang LC, et al. The acoustic radiation force impulse elastography evaluation of liver fibrosis in post - transplantation dysfunction of living donor liver transplantation. Transplant Proc. 2014;46(3): Pinto J, Matos H, Nobre S, et al. Comparison of acoustic radiation force impulse/serum noninvasive markers for fibrosis prediction in liver transplant. J Pediatr Gastroenterol Nutr. 2014;58(3): Tomita H, Hoshino K, Fuchimoto Y, et al. Acoustic radiation force impulse imaging for assessing graft fibrosis after pediatric living donor liver transplantation: a pilot study. Liver Transpl. 2013;19(11):
The role of ARFI and APRI in diagnosis of liver fibrosis on patients with common chronic liver diseases
RESEARCH ARTICLE The role of ARFI and APRI in diagnosis of liver fibrosis on patients with common chronic liver diseases Objective: This study aimed to investigate the value of liver fibrosis assessment
More informationEvaluation of liver and spleen stiffness using a ultrasound guided method: Accuracy of ARFI(R) measurements in liver disease patients
Evaluation of liver and spleen stiffness using a ultrasound guided method: Accuracy of ARFI(R) measurements in liver disease patients Poster No.: C-3242 Congress: ECR 2010 Type: Topic: Authors: Keywords:
More informationEvaluation of liver and spleen stiffness using a ultrasound guided method: Accuracy of ARFI(R) measurements in liver disease patients
Evaluation of liver and spleen stiffness using a ultrasound guided method: Accuracy of ARFI(R) measurements in liver disease patients Poster No.: C-3242 Congress: ECR 2010 Type: Topic: Authors: Keywords:
More informationHow useful are ARFI elastography cut-off values proposed by metaanalysis for predicting the significant fibrosis and compensated liver cirrhosis?
Original papers Med Ultrason 2015, Vol. 17, no. 2, 200-205 DOI: 10.11152/mu.2013.2066.172.arfi How useful are ARFI elastography cut-off values proposed by metaanalysis for predicting the significant fibrosis
More informationPROPOSTA DI UN NUOVO ALGORIMO PER LA DIAGNOSI ECOGRAFICA DELLE MALATTIE CRONICHE DEL FEGATO
PROPOSTA DI UN NUOVO ALGORIMO PER LA DIAGNOSI ECOGRAFICA DELLE MALATTIE CRONICHE DEL FEGATO A. Giorgio Direttore del servizio di Ecografia Interventistica Istituto Clinico S.Rita -IRCCS -Atripalda (Avellino)
More informationMedical Review Approaches to the Diagnosis of Liver Fibrosis
Medical Review Approaches to the Diagnosis of Liver Fibrosis Hiroko Iijima Department of Hepatobiliary and Pancreatic Disease Ultrasound Imaging Center, Hyogo College of Medicine Hiroko Iijima Department
More informationThe role of non-invasivemethods in evaluating liver fibrosis of patients with non-alcoholic steatohepatitis
The role of non-invasivemethods in evaluating liver fibrosis of patients with non-alcoholic steatohepatitis Objectives: Liver biopsy is the gold standard for diagnosing the extent of fibrosis in NAFLD/NASH;
More informationComparative study between two point Shear Wave Elastographic. Acoustic Radiation Force Impulse (ARFI) elastography
Original papers Med Ultrason 2014, Vol. 16, no. 4, 309-314 DOI: Comparative study between two point Shear Wave Elastographic techniques: Acoustic Radiation Force Impulse (ARFI) elastography and ElastPQ
More informationResearch Elastography: Liver
Research Elastography: Liver Giovanna Ferraioli EFSUMB Ultrasound Learning Center Ultrasound Unit - Infectious Diseases Dept. Fondazione IRCCS Policlinico S. Matteo Medical School University of Pavia,
More informationOriginal papers Med Ultrason 2013, Vol. 15, no. 4,
Original papers Med Ultrason 2013, Vol. 15, no. 4, 268-272 DOI: How many measurements are needed for liver stiffness assessment by 2D-Shear Wave Elastography (2D-SWE) and which value should be used: the
More informationAcoustic Radiation Force Imaging(ARFI) and Transient Elastography(TE) for liver fibrosis assessment in chronic viral hepatitis
Acoustic Radiation Force Imaging(ARFI) and Transient Elastography(TE) for liver fibrosis assessment in chronic viral hepatitis Poster No.: C-2115 Congress: ECR 2013 Type: Scientific Exhibit Authors: A.
More informationTransient elastography in chronic viral liver diseases
4 th AISF POST-MEETING COURSE Roma, 26 Febbraio 2011 Transient elastography in chronic viral liver diseases CRISTINA RIGAMONTI, M.D., Ph.D. Transient elastography (TE): a rapid, non-invasive technique
More informationMR Elastography of Liver
MR Elastography of Liver Sudhakar K. Venkatesh, MD, FRCR Professor of Radiology Mayo Clinic College of Medicine Consultant, Abdominal Division Radiology, Mayo Clinic Rochester, MN, USA 19 th May 2018 2018
More informationXiao-Ping Ye, MM, Hai-Tao Ran, MD, Juan Cheng, MM, Ye-Feng Zhu, MM, Da-Zhi Zhang, MD, Ping Zhang, MD, Yuan-Yi Zheng, MD
ORIGINAL RESEARCH Liver and Spleen Stiffness Measured by Acoustic Radiation Force Impulse Elastography for Noninvasive Assessment of Liver Fibrosis and Esophageal Varices in Patients With Chronic Hepatitis
More informationClinical Medicine Review
Dighe M. et al. Clinical Medicine Review, 2018 Page 1 of 15 Clinical Medicine Review Published: July 09, 2018 Citation: Dighe M. et al. (2018) Review of ultrasound elastography techniques in the liver.
More informationULTRASOUND IN CHRONIC LIVER DISEASE
ULTRASOUND IN CHRONIC LIVER DISEASE Prof. Ioan Sporea, MD, PhD Head of Department of Gastroenterology and Hepatology University of Medicine and Pharmacy, Timişoara, Romania WFUMB Center of Education (COE),
More informationRSNA-QIBA SWS Profile What the Clinical Workflow Would look like and a Review of Biological Confounders. Manish Dhyani, MD Anthony Samir, MD MPH
RSNA-QIBA SWS Profile What the Clinical Workflow Would look like and a Review of Biological Confounders Manish Dhyani, MD Anthony Samir, MD MPH Background Liver fibrosis is the final common pathway for
More informationFibrosis & Structural Decline of Liver Allografts: what and how to measure & potential underlying causes. Carla Venturi Monteagudo MD, PhD
Fibrosis & Structural Decline of Liver Allografts: what and how to measure & potential underlying causes Carla Venturi Monteagudo MD, PhD THE NORMAL LIVER ARCHITECTURE Parenchymal Cells -Hepatocytes -Cholangiocytes
More informationNon-Invasive Testing for Liver Fibrosis
NORTHWEST AIDS EDUCATION AND TRAINING CENTER Non-Invasive Testing for Liver Fibrosis John Scott, MD, MSc Associate Professor, University of Washington Associate Clinic Director, Hep/Liver Clinic, Harborview
More informationiu22 Liver Shear Wave ElastPQ
iu22 Liver Shear Wave ElastPQ Clinical Case Study Lucy Wang Clinical Application Specialist ASEAN Case Study: History: 58-year-old male patient, hepatitis B virus (HBV) carrier, with non clinical symptoms
More informationNon-Invasive Assessment of Liver Fibrosis. Patricia Slev, PhD University of Utah Department of Pathology
Non-Invasive Assessment of Liver Fibrosis Patricia Slev, PhD University of Utah Department of Pathology Disclosure Patricia Slev has no relevant financial relationships to disclose. 2 Chronic Liver Disease
More informationLiver elastography ultrasound cpt code
Liver elastography ultrasound cpt code In a multi-center study, Barbero-Villares et al (2012) evaluated the presence of significant liver fibrosis by transient elastography (FibroScan) in inflammatory.
More informationImproved Hepatic Fibrosis Grading Using Point Shear Wave Elastography and Machine Learning
Improved Hepatic Fibrosis Grading Using Point Shear Wave Elastography and Machine Learning Presenter: Hersh Sagreiya 1, M.D. Authors: Alireza Akhbardeh 1, Ph.D., Isabelle Durot 1, M.D., Carlo Filice 2,
More informationLiver imaging the revolution
Liver imaging the revolution Valérie Vilgrain Hôpital Beaujon, Paris, France PHC 2018 - www.aphc.info At the Beginning of the story Radiology in the 1970s US Garrett Radiology 1976 abscess Taylor Radiology
More informationOriginal Article Gastrointestinal Imaging
Original Article Gastrointestinal Imaging http://dx.doi.org/10.3348/kjr.2016.17.5.750 pissn 1229-6929 eissn 2005-8330 Korean J Radiol 2016;17(5):750-757 Prospective Comparison of Liver Stiffness Measurements
More informationNONINVASIVE IMAGING METHODS FOR ASSESSMENT OF LIVER DAMAGE IN NASH
NONINVASIVE IMAGING METHODS FOR ASSESSMENT OF LIVER DAMAGE IN NASH Bachir Taouli, MD Director of Body MRI and Cancer Imaging Program Department of Radiology / Translational and Molecular Imaging Institute
More informationTransient elastography the state of the art
Transient elastography the state of the art Laurent CASTERA, MD PhD Department of Hepatology, Hôpital Beaujon, Clichy Université Paris-7, France White Nights of Hepatology, St Petersburg, Russia, june
More informationAcoustic radiation force impulse (ARFI): a review of an useful technique to assess liver stiffness
Acoustic radiation force impulse (ARFI): a review of an useful technique to assess liver stiffness Poster No.: C-2166 Congress: ECR 2013 Type: Educational Exhibit Authors: M. Elorz, A. Benito, L. Garcia
More informationWorld Journal of Radiology. Is ARFI elastography reliable for predicting fibrosis severity in chronic HCV hepatitis?
W J R World Journal of Radiology Online Submissions: http://www.wjgnet.com/1949-847office wjr@wjgnet.com doi:1.4329/wjr.v3.i7.188 World J Radiol 211 July 28; 3(7): 188-193 ISSN 1949-847 (online) 211 Baishideng.
More informationClinical Policy Title: Liver elastography
Clinical Policy Title: Liver elastography Clinical Policy Number: CCP.1118 Effective Date: October 1, 2014 Initial Review Date: June 18, 2014 Most Recent Review Date: August 7, 2018 Next Review Date: August
More informationByung Ihn Choi, M.D. Department of Radiology Seoul National University Hospital
Byung Ihn Choi, M.D. Department of Radiology Seoul National University Hospital CEUS & US Elastography : Contents CEUS Introduction Contrast agents & imaging Clinical application US Video WS Summary US
More informationOriginal papers Med Ultrason 2013, Vol. 15, no. 2, Ioan Sporea, Iulia Raţiu, Simona Bota, Roxana Şirli, Ana Jurchiş
Original papers Med Ultrason 2013, Vol. 15, no. 2, 111-115 DOI: 10.11152/mu.2013.2066.152.is1ir2 Are different cut-off values of liver stiffness assessed by Transient Elastography according to the etiology
More informationDISCLOSURES. This activity is jointly provided by Northwest Portland Area Indian Health Board and Cardea
DISCLOSURES This activity is jointly provided by Northwest Portland Area Indian Health Board and Cardea Cardea Services is approved as a provider of continuing nursing education by Montana Nurses Association,
More informationMedical Policy Non-invasive Tests for Hepatic Fibrosis
Medical Policy Non-invasive Tests for Hepatic Fibrosis Subject: Non-invasive Tests for Hepatic Fibrosis Background: Accurately diagnosing liver fibrosis and inflammatory activity are the most important
More informationUpdate on Non-Alcoholic Fatty Liver Disease. Timothy R. Morgan, MD Chief, Hepatology, VA Long Beach Professor of Medicine, UCI
Update on Non-Alcoholic Fatty Liver Disease Timothy R. Morgan, MD Chief, Hepatology, VA Long Beach Professor of Medicine, UCI February 3, 2018 Disclosure Clinical trials: Genfit Speaker s Bureau: none
More informationMedical technologies guidance Published: 23 September 2015 nice.org.uk/guidance/mtg27
Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and C Medical technologies guidance Published: 23 September 2015 nice.org.uk/guidance/mtg27 NICE 2017. All rights
More informationClinical Policy Title: Noninvasive assessment of hepatic fibrosis
Clinical Policy Title: Noninvasive assessment of hepatic fibrosis Clinical Policy Number: 08.01.03 Effective Date: Oct. 1, 2014 Initial Review Date: June 18, 2014 Most Recent Review Date: August 17, 2017
More informationResearch Article Utility of Shear Wave Elastography for Diagnosing Chronic Autoimmune Thyroiditis
yroid Research Volume 2015, Article ID 164548, 5 pages http://dx.doi.org/10.1155/2015/164548 Research Article Utility of Shear Wave Elastography for Diagnosing Chronic Autoimmune Thyroiditis Takahiro Fukuhara,
More informationUltrasound elastography in abdominal imaging
Ultrasound elastography in abdominal imaging Olivier ucidarme Pitié Salpêtrière - UPMC Paris France Ultraschall Med. 013 Apr;34():169-84 Ultraschall Med. 013 Jun;34(3):38-53. US elastography Ultraschall
More informationElastography in the. technically difficult patient. EPIQ ultrasound system. Ultrasound
Ultrasound Elastography in the technically difficult patient EPIQ ultrasound system Chairman Department of Diagnostic Radiology Allegheny General Hospital Pittsburgh, PA, USA You can offer more information
More informationOriginal Article. Abstract. Background
E2 Original Article THIEME Evaluation of Acoustic Radiation Force Impulse Imaging (ARFI) for the Determination of Liver Stiffness Using Transient Elastography as a Reference in Children Authors A. Sagir
More informationNONINVASIVE TECHNIQUES FOR EVALUATION AND MONITORING OF CHRONIC LIVER DISEASE
LIVER DISEASE Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs are
More informationUltrasound elastography of liver: How Radiologist can help.
116 Review Article Ultrasound elastography of liver: How Radiologist can help. Maharjan S 1, Panta OB 2, Lohani B 1, Pathak YR 2, Ansari MA 1 1 Department of radiology and Imaging, Tribhuvan University
More informationPrediction of Hepatocellular Carcinoma Incidence Risk by Ultrasound Elastography
2235-1795/14/0031-0001$39.50/0 1 Editorial Prediction of Hepatocellular Carcinoma Incidence Risk by Ultrasound Elastography Prof. M. Kudo Editor Liver Cancer In patients with chronic hepatitis and continuous
More informationDoppler Ultrasonography Findings of Splenic Arterial Steal Syndrome After Liver Transplant
article Doppler Ultrasonography Findings of Splenic Arterial Steal Syndrome After Liver Transplant Nihal Uslu, 1 Hulya Aslan, 1 Huseyin Gurkan Tore, 2 Gokhan Moray, 3 Hamdi Karakayali, 4 Fatih Boyvat,
More informationNon-invasive assessment of liver fibrosis using ARFI with pathological correlation, a prospective study
440 Yap WW, et al., 2013; 12 (4): 440-447 ORIGINAL ARTICLE July-August, Vol. 12 No.4, 2013: 440-447 Non-invasive assessment of liver fibrosis using ARFI with pathological correlation, a prospective study
More informationLiver Shear-Wave Velocity and Serum Fibrosis Markers to Diagnose Hepatic Fibrosis in Patients with Chronic Viral Hepatitis B
Original Article Gastrointestinal Imaging http://dx.doi.org/10.3348/kjr.2016.17.3.396 pissn 1229-6929 eissn 2005-8330 Korean J Radiol 2016;17(3):396-404 Liver Shear-Wave Velocity and Serum Fibrosis Markers
More informationUltrasound Transient Elastography for Liver Fibrosis
Ultrasound Transient Elastography for Liver Fibrosis Protocol: RAD042 Effective Date: June 1, 2018 Table of Contents Page COMMERCIAL, MEDICARE & MEDICAID COVERAGE RATIONALE... 1 DESCRIPTION OF SERVICES...
More informationTissue Strain Analytics Virtual Touch Tissue Imaging and Quantification
Whitepaper Tissue Strain Analytics Virtual Touch Tissue Imaging and Quantification ACUSON S2000 Ultrasound System Answers for life. Page 1 Tissue Strain Analytics: Virtual Touch Tissue Imaging and Quantification
More informationOverall Goals and Objectives for Transplant Hepatology EPAs:
Overall Goals and Objectives for Transplant Hepatology EPAs: 1. DIAGNOSTIC LIST During the one-year Advanced Pediatric Transplant Hepatology Program, fellows are expected to develop comprehensive skills
More informationJPGN Journal of Pediatric Gastroenterology and Nutrition Publish Ahead of Print
JPGN Journal of Pediatric Gastroenterology and Nutrition Publish Ahead of Print DOI : 10.1097/MPG.0000000000000489 Points to be considered when Applying FibroScan S Probe for Children with Biliary Atresia
More informationCONFOUNDING FACTORS affecting the performance of US elastography
Clinical Ultrasound in Hepatology: Training for Hepatologists UCL Institute for Liver and Digestive Health, Royal Free Hospital, London, UK June 2018 CONFOUNDING FACTORS affecting the performance of US
More informationMotion effects on the measurement of stiffness on ultrasound shear wave elastography: a moving liver fibrosis phantom study
Original papers Med Ultrason 2018, Vol. 20, no. 1, 14-20 DOI: 10.11152/mu-1138 Motion effects on the measurement of stiffness on ultrasound shear wave elastography: a moving liver fibrosis phantom study
More informationPreliminary clinical experience with Shear Wave Dispersion Imaging for liver viscosity
Preliminary clinical experience with Shear Wave Dispersion Imaging for liver viscosity Dr. Katsutoshi Sugimoto Department of Gastroenterology and Hepatology, Tokyo Medical University, Japan Introduction
More informationEuropean. Young Hepatologists Workshop. Organized by : Quantification of fibrosis and cirrhosis outcomes
supported by from Gilea Quantification of fibrosis and cirrhosis outcomes th 5 European 5 European Young Hepatologists Workshop Young Hepatologists Workshop August, 27-29. 2015, Moulin de Vernègues Vincenza
More informationNon-invasive diagnosis of hepatitis B virus-related cirrhosis
Online Submissions: http://www.wjgnet.com/esps/ bpgoffice@wjgnet.com doi:10.3748/wjg.v20.i2.445 World J Gastroenterol 2014 January 14; 20(2): 445-459 ISSN 1007-9327 (print) ISSN 2219-2840 (online) 2014
More informationNoninvasive Techniques for the Evaluation and Monitoring of Patients With Chronic Liver Disease
Noninvasive Techniques for the Evaluation and Monitoring of Patients With Chronic Liver Disease Policy Number: 2.04.41 Last Review: 2/2019 Origination: 2/2017 Next Review: 2/2020 Policy Blue Cross and
More informationACOUSTIC RADIATION FORCE IMAGING (ARFI) in assessment of renal stiffness in patients with chronic kidney disease
ACOUSTIC RADIATION FORCE IMAGING (ARFI) in assessment of renal stiffness in patients with chronic kidney disease Poster No.: C-2134 Congress: ECR 2013 Type: Scientific Exhibit Authors: M. Januszewicz 1,
More informationQuantitative measurement of ultrasound attenuation and Hepato- Renal Index in Non-Alcoholic Fatty Liver Disease
Original papers Med Ultrason 2013, Vol. 15, no. 1, 16-22 DOI: 10.11152/mu.2013.2066.151.hlv1qmu2 Quantitative measurement of ultrasound attenuation and Hepato- Renal Index in Non-Alcoholic Fatty Liver
More informationMeta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis
Liver International ISSN 1478-3223 REVIEW ARTICLE Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis Simona Bota 1, Harald Herkner 2, Ioan Sporea 1, Petra
More informationAcoustic radiation force impulse elastography in distinguishing hepatic haemangiomata from metastases: preliminary observations
The British Journal of Radiology, 84 (2011), 939 943 SHORT COMMUNICATION Acoustic radiation force impulse elastography in distinguishing hepatic haemangiomata from metastases: preliminary observations
More informationshear wave elastography
Ultrasound ElastQ Imaging Introducing next-generation shear wave elastography Philips ElastQ Imaging Vijay Shamdasani, PhD and Hua Xie, PhD, Philips Ultrasound Tissue stiffness has long provided important
More informationBasic patterns of liver damage what information can a liver biopsy provide and what clinical information does the pathologist need?
Basic patterns of liver damage what information can a liver biopsy provide and what clinical information does the pathologist need? Rob Goldin r.goldin@imperial.ac.uk Fatty liver disease Is there fatty
More informationEvaluation of Liver Fibrosis using ShearWave Elastography on Aixplorer
Evaluation of Liver Fibrosis using ShearWave Elastography on Aixplorer SSID02892-01 November 2012 Evaluation of Liver Fibrosis using SWE on Aixplorer Introduction From a clinical standpoint, staging liver
More informationUltrasound Elastography Used for Preventive Non-Invasive Screening in Early Detection of Liver Fibrosis
Elmer ress Original Article J Clin Med Res. 2016;8(9):650-655 Ultrasound Elastography Used for Preventive Non-Invasive Screening in Early Detection of Liver Fibrosis Florian Bert a, c, Jona T. Stahmeyer
More informationHepatic Imaging: What Every Practitioner Should Know
Hepatic Imaging: What Every Practitioner Should Know Shuchi K. Rodgers, MD Section Chief, Abdominal Imaging Director of Ultrasound Department of Radiology Einstein Medical Center rodgerss@einstein.edu
More informationRadiology Update 2017
Radiology Update 2017 John K. Phillips, MD Affiliated Assistant Professor of Radiology University of Tennessee Health Sciences Center Chief, Radiology and Nuclear Medicine VA Memphis Disclosures Financial:
More informationNoninvasive Techniques for the Evaluation and Monitoring of Patients With Chronic Liver Disease
Noninvasive Techniques for the Evaluation and Monitoring of Patients With Chronic Liver Disease Policy Number: 2.04.41 Last Review: 2/2018 Origination: 2/2017 Next Review: 2/2019 Policy Blue Cross and
More informationNew Tools for Assessing Disease Sererity, progression and regression in HBV and HCV
New Tools for Assessing Disease Sererity, progression and regression in HBV and HCV Jidong Jia, MD, PhD Beijing Friendship Hospital, Capital Medical University 2016-3-14 Disclosure Consultation for Abbvie
More informationM30 Apoptosense ELISA. A biomarker assay for detection and screening of NASH
M30 Apoptosense ELISA A biomarker assay for detection and screening of NASH NASH A Global Disease In the Western countries, Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common liver disease, strongly
More informationAcoustic Radiation Force Impulse Imaging for Assessing Graft Fibrosis After Pediatric Living Donor Liver Transplantation: A Pilot Study
LIVER TRANSPLANTATION 19:1202 1213, 2013 ORIGINAL ARTICLE Acoustic Radiation Force Impulse Imaging for Assessing Graft Fibrosis After Pediatric Living Donor Liver Transplantation: A Pilot Study Hirofumi
More informationReal-Time Elastography Applications in Liver Pathology between Expectations and Results
CLINICAL IMAGING Real-Time Elastography Applications in Liver Pathology between Expectations and Results Larisa Sandulescu, Ion Rogoveanu, Ioana Andreea Gheonea, Sergiu Cazacu, Adrian Saftoiu Research
More informationHEPATIC ELASTOGRAPHY AND FIB-4 SCORE VERSUS LIVER BIOPSY FOR ASSESSMENT OF LIVER FIBROSIS IN CHRONIC HCV PATIENTS
HEPATIC ELASTOGRAPHY AND FIB-4 SCORE VERSUS LIVER BIOPSY FOR ASSESSMENT OF LIVER FIBROSIS IN CHRONIC HCV PATIENTS Essam A. Wahab*, Talaat Fathy** Sameh Saber*** and Hanan S. Ahmad**** Internal Medicine*,
More informationQuantitative assessment of the elasticity values of liver with shear wave ultrasonographic elastography
Indian J Med Res 137, May 2013, pp 911-915 Quantitative assessment of the elasticity values of liver with shear wave ultrasonographic elastography Kemal Arda, Nazan Ciledag *, Bilgin Kadri Arıbas, Elif
More informationAcoustic Radiation Force Impulse (ARFI) of the pancreas.
Acoustic Radiation Force Impulse (ARFI) of the pancreas. Poster No.: C-0686 Congress: ECR 2014 Type: Educational Exhibit Authors: S. Crosara, M. D'Onofrio, R. De Robertis, S. Canestrini, E. Demozzi, R.
More informationAccuracy of Liver Surface Nodularity Quantification on MDCT as a Noninvasive Biomarker for Staging Hepatic Fibrosis
Gastrointestinal Imaging Original Research Pickhardt et al. MDCT of Hepatic Fibrosis Gastrointestinal Imaging Original Research Perry J. Pickhardt 1 Kyle Malecki John Kloke Meghan G. Lubner Pickhardt PJ,
More informationBio Predictive. FibroTest Scientific Publications. Ratziu 2016 FibroMax NASH. Friedman 2016 FibroTest NASH EASL Key Publications for 2017
EASL 2017 Scientific Publications Ratziu 2016 NASH Friedman 2016 NASH SteatoTest and sensitive markers of improvement in NASH trial using Elafibranor Elafibranor, an agonist of the peroxisome proliferator
More informationAspartate aminotransferase-to-platelet ratio index in children with cholestatic liver diseases to assess liver fibrosis
The Turkish Journal of Pediatrics 2015; 57: 492-497 Original Aspartate aminotransferase-to-platelet ratio index in children with cholestatic liver diseases to assess liver fibrosis Aysel Ünlüsoy-Aksu 1,
More informationNoninvasive Diagnosis and Staging of Liver Disease. Naveen Gara, MD
Noninvasive Diagnosis and Staging of Liver Disease Naveen Gara, MD Outline Brief overview of the anatomy of liver Liver-related lab tests Chronic liver disease progression Estimation of liver fibrosis
More informationFactors Influencing the Diagnostic Accuracy of Acoustic Radiation Force Impulse Elastography in Patients with Chronic Hepatitis B
Gut and Liver, Vol. 1, No. 2, March 216, pp. 275-282 ORiginal Article Factors Influencing the Diagnostic Accuracy of Acoustic Radiation Force Impulse Elastography in Patients with Chronic Hepatitis B Mi
More informationpulse See the brain as never before. GE Healthcare s i g n a page 51
GE Healthcare pulse s i g n a t h e m ag a z i n e o f m r s p r i n g 2 0 1 0 See the brain as never before. Non-contrast enhanced perfusion assessment brings neuro imaging one step closer to the future
More informationWhy to biopsy? Indications for liver biopsy in common medical liver diseases- how are they changing?
Why to biopsy? Indications for liver biopsy in common medical liver diseases- how are they changing? Stephen D Ryder Nottingham University Hospitals NHS Trust and Biomedical research Unit What are we currently
More informationNovel multiparametric magnetic resonance elastography (MRE) protocol accurately predicts NAS score for NASH diagnosis
Novel multiparametric magnetic resonance elastography (MRE) protocol accurately predicts NAS score for NASH diagnosis Alina M. Allen, Meng Yin, Sudhakar K. Venkatesh, Taofic Mounajjed, Todd A. Kellogg,
More informationIn Search of New Biomarkers for Nonalcoholic Fatty Liver Disease
REVIEW In Search of New Biomarkers for Nonalcoholic Fatty Liver Disease Ting-Ting Chan, M.R.C.P., and Vincent Wai-Sun Wong, M.D. Nonalcoholic fatty liver disease (NAFLD) affects 15% to 40% of the general
More informationQuantitative Assessment of Normal Soft-Tissue Elasticity Using Shear-Wave Ultrasound Elastography
Special Article Original Research Arda et al. Soft-Tissue Elasticity in Ultrasound Elastography Special Article Original Research JOURNAL CLUB Kemal Arda 1 Nazan Ciledag 1 Elif Aktas 1 Bilgin Kadri Arıbas
More informationNHSScotland is required to consider the Scottish Health Technologies Group (SHTG) advice.
Advice Statement 010-18 July 2018 Advice Statement What is the most accurate and cost-effective direct test (ELF test, hyaluronic acid, P3NP, Fibroscan or ARFI elastography) for detecting and staging liver
More informationNoninvasive Assessment of Liver Fibrosis in Egyptian Children with Chronic Liver Diseases.
Curr Pediatr Res 2016; 20 (1&2): 57-63 ISSN 0971-9032 www.currentpediatrics.com Noninvasive Assessment of Liver Fibrosis in Egyptian Children with Chronic Liver Diseases. Tawhida Abdel Ghaffar 1, Azza
More informationGE Healthcare. MR-Touch MR Elastography. pulse. imagination at work APPLICATION MONOGRAPH
GE Healthcare MR-Touch MR Elastography imagination at work pulse S I G N A APPLICATION MONOGRAPH Table of Contents Healthymagination Source MR Elastography Healthymagination Validation....................
More informationElastography to Assess the Stage of Liver Fibrosis in Children: Concepts, Opportunities, and Challenges
REVIEW Elastography to Assess the Stage of Liver Fibrosis in Children: Concepts, Opportunities, and Challenges Suraj D. Serai, Ph.D.,* Andrew T. Trout, M.D.,* and Claude B. Sirlin, M.D. WHAT IS ELASTOGRAPHY?
More informationShear Wave Elastography In Characterization Of Liver Tumours
Shear Wave Elastography In Characterization Of Liver Tumours Poster No.: C-1921 Congress: ECR 2014 Type: Scientific Exhibit Authors: K. L. Choong 1, B. J. J. Abdullah 1, G. Kumar 2, C. H. Yeong 1, K. L.
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Noninvasive Techniques for the Evaluation and Monitoring of Page 1 of 38 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Noninvasive Techniques for the Evaluation
More informationPOWERED BY. Innovation in liver disease management
POWERED BY VCTE Innovation in liver disease management An intelligent solution to aid clinical diagnosis, FibroScan uses state of the art fibrosis and steatosis quantification with the most advanced non-invasive
More informationImaging of liver and pancreas
Imaging of liver and pancreas.. Disease of the liver Focal liver disease Diffusion liver disease Focal liver disease Benign Cyst Abscess Hemangioma FNH Hepatic adenoma HCC Malignant Fibrolamellar carcinoma
More informationPilot study on the use of acoustic radiation force impulse imaging in the staging of cystic fibrosis associated liver disease
Journal of Cystic Fibrosis 11 (2012) 427 432 www.elsevier.com/locate/jcf Original Article Pilot study on the use of acoustic radiation force impulse imaging in the staging of cystic fibrosis associated
More informationUltrasound Committee Activities
Ultrasound Committee Activities Anthony E. Samir MD MPH Clinical Director MGH/MIT Center for Ultrasound Research & Translation PINTAD 2014 Disclosures Grant Support Harvard Catalyst: Pilot Grant (NIBIB
More informationRole of Liver Biopsy. Role of Liver Biopsy 9/3/2009. Liver Biopsies in Viral Hepatitis: Beyond Grading and Staging
Liver Biopsies in Viral Hepatitis: Beyond Grading and Staging for further reference: Liver biopsy assessment in chronic viral hepatitis: a personal, practical approach Neil Theise, MD. Depts of Pathology
More informationNON INVASIVE ASSESSMENT OF LIVER FIBROSIS : FIBROSCAN
NON INVASIVE ASSESSMENT OF LIVER FIBROSIS : FIBROSCAN M. Beaugrand Service d Hépatologied Hopital J. Verdier BONDY 93143 et Université Paris XIII MAINZ 21.09.2008 ASSESSMENT OF FIBROSIS : WHY? Management
More informationDiagnostic TRUS Elastography of the Prostate
Diagnostic TRUS Elastography of the Prostate George Zacharopoulos Department of Diagnostic Ultrasound Hygeia Hospital Athens, Greece Prostate HI-RTE Why we need Elastography Better Detection of possible
More informationPretreatment Evaluation
Pretreatment Evaluation Disclosures Research supported by Gilead Sciences Inc.: Site investigator for HIV/HCV SWITCH Registry Study Key personnel for FOCUS HCV Screening Program through Vanderbilt University
More information